Abstract
The Aβ peptide has been identified as central to the onset and development of Alzheimers disease (AD) and several hypotheses about toxicity involving Aβ peptides have been proposed including mechanisms of oxidative stress and disruption of calcium homeostasis. The biology, structure and physical properties of Aβ peptides are discussed, as well as existing therapeutics and future strategies for the treatment of AD.
Keywords: amyloid, peptide, alzheimers disease, structure, therapeutic
Protein & Peptide Letters
Title: The Role of Aβ Peptides in Alzheimers Disease
Volume: 12 Issue: 6
Author(s): Anna K. Tickler, John D. Wade and Frances Separovic
Affiliation:
Keywords: amyloid, peptide, alzheimers disease, structure, therapeutic
Abstract: The Aβ peptide has been identified as central to the onset and development of Alzheimers disease (AD) and several hypotheses about toxicity involving Aβ peptides have been proposed including mechanisms of oxidative stress and disruption of calcium homeostasis. The biology, structure and physical properties of Aβ peptides are discussed, as well as existing therapeutics and future strategies for the treatment of AD.
Export Options
About this article
Cite this article as:
Tickler K. Anna, Wade D. John and Separovic Frances, The Role of Aβ Peptides in Alzheimers Disease, Protein & Peptide Letters 2005; 12 (6) . https://dx.doi.org/10.2174/0929866054395905
DOI https://dx.doi.org/10.2174/0929866054395905 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Status of Carotid Stenting
Current Vascular Pharmacology Biological Basis of Ageing, Age-related Diseases and Interventions
Current Pharmacogenomics and Personalized Medicine New Insight in Antiplatelet Therapy Monitoring in Cardiovascular Patients: From Aspirin to Thienopyridine
Cardiovascular & Hematological Disorders-Drug Targets Vascular Disease and Risk Factors in Chronic Kidney Disease
Vascular Disease Prevention (Discontinued) Thrombolytic Treatment of Cardiac Myxoma-Induced Ischemic Stroke: A Review
Current Drug Safety Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment
Current Pharmaceutical Design Increased Risk of Dementia in Patients with Non-Apnea Sleep Disorder
Current Alzheimer Research Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System
Current Neuropharmacology 2,4,6-Trichlorophenylhydrazine Schiff Bases as DPPH Radical and Super Oxide Anion Scavengers
Medicinal Chemistry Heavy Metal Toxicity in Humans and its Preventive and Control Measures
Current Nutrition & Food Science Cyclooxygenase Inhibitors: Instrumental Drugs to Understand Cardiovascular Homeostasis and Arterial Thrombosis
Cardiovascular & Hematological Disorders-Drug Targets Expanded Temporal Binding Windows in People with Mild Cognitive Impairment
Current Alzheimer Research The Effect of Potato Almond Orange Cookies on their Weight, BMI, Hemoglobin, and Lymphocyte Status of Undernourished Older People during COVID-19 Pandemic
Current Nutrition & Food Science Modulation Effects of Piracetam and Ginkgo biloba on the Cognitive and Working Memory Functions: Psychometric Study
Current Psychopharmacology Microbial Interaction of Periodontopathic Bacterium Porphyromonas gingivalis and HIV-Possible Causal Link of Periodontal Diseases to AIDS Progression-
Current HIV Research Pharmacogenomics in Psychiatry: Implications for Practice
Recent Patents on Biotechnology Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design The Role of Annexin A1 and Formyl Peptide Receptor 2/3 Signaling in Chronic Corticosterone-Induced Depression-Like behaviors and Impairment in Hippocampal-Dependent Memory
CNS & Neurological Disorders - Drug Targets Short-Term Response to Cholinesterase Inhibitors in Alzheimer’s Disease Delays Time to Nursing Home Placement
Current Alzheimer Research Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology